These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 9230743

  • 41. Cystic fibrosis sputum: a barrier to the transport of nanospheres.
    Sanders NN, De Smedt SC, Van Rompaey E, Simoens P, De Baets F, Demeester J.
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1905-11. PubMed ID: 11069833
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis.
    Homnick DN, Marks JH, Rubin BK.
    J Aerosol Med; 2007 Nov; 20(1):45-9. PubMed ID: 17388752
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability.
    Wills PJ, Wodehouse T, Corkery K, Mallon K, Wilson R, Cole PJ.
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):413-7. PubMed ID: 8756815
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.
    Harms HK, Matouk E, Tournier G, von der Hardt H, Weller PH, Romano L, Heijerman HG, FitzGerald MX, Richard D, Strandvik B, Kolbe J, Kraemer R, Michalsen H.
    Pediatr Pulmonol; 1998 Sep; 26(3):155-61. PubMed ID: 9773909
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. The use of pulmonary clearance medications in the acutely ill patient.
    Papacostas MF, Luckett P, Hupp S.
    Expert Rev Respir Med; 2017 Oct; 11(10):815-826. PubMed ID: 28780895
    [Abstract] [Full Text] [Related]

  • 58. Aerosolized dornase alpha (rhDNase) in cystic fibrosis.
    Bates RD, Nahata MC.
    J Clin Pharm Ther; 1995 Dec; 20(6):313-5. PubMed ID: 8847368
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.